High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling

References

Page 1

	Year	Citations
Cancer statistics, 2019 Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal CA A Cancer Journal for Clinicians Epidemiology Of CancerPopulation Health SciencesHealth DisparitiesCancer RegistrationMortality Rates	2019	20.7K
Circular RNAs are a large class of animal RNAs with regulatory potency Sebastian Memczak, Marvin Jens, Antigoni Elefsinioti, Nature BiologyCircular RnasNatural SciencesGeneticsRegulatory Potency	2013	8.3K
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Howard I. Scher, Karim Fizazi, Fred Saad, New England Journal of Medicine	2012	4.5K
Circular RNAs are abundant, conserved, and associated with ALU repeats William R. Jeck, Jessica A. Sorrentino, Kai Wang, RNA	2012	4.5K
Cancer treatment and survivorship statistics, 2019 Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto, CA A Cancer Journal for Clinicians Surgical OncologyCancer PrevalenceCancer ManagementEpidemiology Of CancerCancer Registration	2019	4.4K
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, New England Journal of Medicine	2012	2.8K
Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis Ivano Legnini, Gaia Di Timoteo, Francesca Rossi, Molecular Cell	2017	2.3K
Translation of CircRNAs Nagarjuna Reddy Pamudurti, Osnat Bartok, Marvin Jens, Molecular Cell	2017	1.8K
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer Ian D. Davis, Andrew Martin, Martin R. Stockler, New England Journal of Medicine	2019	1.5K
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, Journal of Clinical Oncology	2019	1.1K

Page 1